Eficacia de la 4-aminopiridina en el tratamiento de pacientes diagnosticados de ataxia con downbeat nystagmus de causa idiopática [PDF]
, 2012 L'atàxia amb downbeat nystamgus (ADBN) es una síndrome clínica que cursa amb atàxia vestíbulo-cerebel·losa i downbeat nystagmus. Es va valorar la seguretat i eficàcia del bloquejador de canal de potassi 4-aminopiridina (4-AP) pel tractament d'aquesta ...
Latorre Murillo, Pilar +3 more
core
GABAB receptor outward currents are transiently disclosed by the convulsant 4-aminopyridine in vitro. [PDF]
Curr Res Neurobiol, 2023 Cattani A +5 more
europepmc +1 more source
Osborn Waves: History and Significance [PDF]
, 2004 The Osborn wave is a deflection with a dome or hump configuration occurring at the R-ST junction (J point) on the ECG (Fig. 1). In the historical view, different names have been used for this wave in the medical literature, such as “camel-hump sign ...
Atarashi, Hirotsugu +6 more
core +2 more sources
In vivo laser speckle contrast imaging of 4-aminopyridine- or pentylenetetrazole-induced seizures. [PDF]
APL Bioeng, 2023 Wang Y, Tsytsarev V, Liao LD.
europepmc +1 more source
4-aminopyridine acts as a weak base and a Ca2+ mobilizing agent in triggering oocyte meiosis reinitiation and activation in the Japanese clam Ruditapes philippinarum [PDF]
, 1995 Isabelle Gobet +6 more
openalex +1 more source
The phase transitions of 4-aminopyridine-based indolocarbazoles: twinning, local- and pseudo-symmetry [PDF]
, 2019 Thomas Kader +3 more
openalex +1 more source
Mechanism of 4-aminopyridine inhibition of the lysosomal channel TMEM175. [PDF]
Proc Natl Acad Sci U S A, 2022 Oh S +4 more
europepmc +1 more source
Effect of 4-aminopyridine on the rat superior cervical ganglion.
, 1980 Arata Goto, Minoru Watanabe
openalex +1 more source
Effects of 4-Aminopyridine on Combined Nerve and Muscle Injury and Bone Loss. [PDF]
J Hand Surg Am, 2023 Govindappa PK +4 more
europepmc +1 more source
4-Aminopyridine improves real-life gait performance in SCA27B on a single-subject level: a prospective n-of-1 treatment experience. [PDF]
J Neurol, 2023 Seemann J +3 more
europepmc +1 more source